MedPath

Medical University of Vienna

Medical University of Vienna logo
🇦🇹Austria
Ownership
Private
Established
1365-01-01
Employees
1K
Market Cap
-
Website
http://www.meduniwien.ac.at

PlayBionic: Interactive Mobile Training App

Not Applicable
Conditions
Rehabilitation
Interventions
Behavioral: MyoBeatz
First Posted Date
2018-06-06
Last Posted Date
2018-06-06
Lead Sponsor
Medical University of Vienna
Target Recruit Count
8
Registration Number
NCT03547310
Locations
🇦🇹

Medical University of Vienna, CD Laboratory for Restoration of Extremity Function, Vienna, Austria

Vienna Vascular Liver Disease Study

Recruiting
Conditions
Vascular Liver Disease
Porto-sinusoidal Vascular Disorder
Cardiac Cirrhosis
Budd-Chiari Syndrome
Rendu Osler Weber
Portal Vein Thrombosis
Non-Cirrhotic Portal Hypertension
First Posted Date
2018-05-30
Last Posted Date
2024-01-03
Lead Sponsor
Medical University of Vienna
Target Recruit Count
200
Registration Number
NCT03541057
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Maudsley Model of Anorexia Nervosa Treatment for Adolescents and Young Adults (MANTR-a)

Not Applicable
Conditions
Anorexia Nervosa
Anorexia
Interventions
Behavioral: MANTR-a treatment
First Posted Date
2018-05-24
Last Posted Date
2021-03-05
Lead Sponsor
Medical University of Vienna
Target Recruit Count
100
Registration Number
NCT03535714
Locations
🇦🇹

Medical University of Vienna, Dep. of Child and Adolescent Psychiatry, Vienna, Austria

Postoperative Atrial Fibrillation Suppression By Nerve Stimulation

Not Applicable
Conditions
Atrial Fibrillation
Interventions
Device: DUCEST Neurostimulator V Group B
Device: DUCEST Neurostimulator V Group A
First Posted Date
2018-05-23
Last Posted Date
2018-05-23
Lead Sponsor
Medical University of Vienna
Target Recruit Count
42
Registration Number
NCT03533140

Radiofrequency Ablation for the Treatment of Large Symptomatic Heterotopic Gastric Mucosa

Not Applicable
Conditions
Esophagus Disorder
Interventions
Device: Radiofrequency ablation
Procedure: esophagoscopy
First Posted Date
2018-05-08
Last Posted Date
2020-02-20
Lead Sponsor
Medical University of Vienna
Target Recruit Count
44
Registration Number
NCT03518905
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Objective Assessment of Macular Function at Retinal and Cortical Levels

Conditions
Retina Disorder
Macula; Degeneration, Congenital or Hereditary
Interventions
Diagnostic Test: functional magnetic resonance imaging (fMRI)
Diagnostic Test: Microperimetry (MP)
Diagnostic Test: Optical coherence tomography (OCT)
Diagnostic Test: Blue light fundus autofluorescence imaging (FAF)
Diagnostic Test: Visual testing
First Posted Date
2018-05-07
Last Posted Date
2018-05-07
Lead Sponsor
Medical University of Vienna
Target Recruit Count
100
Registration Number
NCT03517241

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients

Phase 3
Completed
Conditions
Hyperglycemia
Interventions
Drug: Human insulin isophane, Humulin N (Eli Lilly)
Drug: Standard of care
Drug: Insulin lispro, Humalog (Eli Lilly) in insulin pump
First Posted Date
2018-04-25
Last Posted Date
2019-02-19
Lead Sponsor
Medical University of Vienna
Target Recruit Count
263
Registration Number
NCT03507829

Metformin Therapy in Non-diabetic AAA Patients

Phase 2
Active, not recruiting
Conditions
Abdominal Aortic Aneurysm
Interventions
First Posted Date
2018-04-25
Last Posted Date
2024-03-28
Lead Sponsor
Medical University of Vienna
Target Recruit Count
170
Registration Number
NCT03507413
Locations
🇦🇹

Medical University of Vienna, Department of Surgery, Division of Vascular Surgery, Vienna, Austria

Balloon Dilation of the Eustachian Tube in Children

Not Applicable
Conditions
Glue Ear
Tube Disorders Eustachian
Interventions
Procedure: Balloon Eustachian Tuboplasty (BET)
First Posted Date
2018-04-17
Last Posted Date
2018-11-14
Lead Sponsor
Medical University of Vienna
Target Recruit Count
50
Registration Number
NCT03499015
Locations
🇦🇹

Medical university of Vienna, Vienna, Austria

Neodolpasse® Infusion Solution Versus Diclofenac 75 mg Infusion in the Treatment of Postoperative Pain After Elective Knee Surgery

Phase 4
Completed
Conditions
Pain, Postoperative
Analgesic Adverse Reaction
Cruciate Ligament Rupture
Interventions
Drug: Neodolpasse
Drug: Placebo
Drug: Diclofenac
First Posted Date
2018-04-10
Last Posted Date
2023-03-20
Lead Sponsor
Medical University of Vienna
Target Recruit Count
72
Registration Number
NCT03493490
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath